Factors Associated With the Place of Death in Huntington Disease: Analysis of Enroll-HD
- 1 July 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Palliative Medicine
- Vol. 26 (7), 915-921
- https://doi.org/10.1089/jpm.2022.0143
Abstract
Background: Most people prefer to die at home. Hospice is the standard in end-of-life care for people with Huntington disease (HD), a neurodegenerative genetic disorder that affects people in middle adulthood. Yet, we have little knowledge regarding the place of death for people with HD. Therefore, the current state of knowledge limits HD clinicians' ability to conduct high-quality goals of care conversations. Objectives: We sought to determine the factors associated with the place of death in people with HD. Design: We obtained cross-sectional data from Enroll-HD and included participants with a positive HD mutation of 36 or more CAG repeats. Results: Out of 16,120 participants in the Enroll-HD study, 536 were reported as deceased. The mean age at death was 60. The leading place of death was home (29%), followed by the hospital (23%). The adjusted odds ratio (aOR) of dying at a skilled nursing facility was significantly lower for those partnered (aOR: 0.48, confidence interval [95% CI]: 0.26–0.86). The aOR for dying on hospice compared to home was increased in a person with some college and above (aOR: 2.40, 95% CI: 1.21–4.75). Conclusions: Our data further suggest that models that predict the place of death for serious illnesses do not appear to generalize to HD. The distribution in the places of death within HD was not uniform. Our findings may assist HD clinicians in communication during goals of care conversations.Keywords
This publication has 23 references indexed in Scilit:
- Is home always the best and preferred place of death?BMJ, 2015
- Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD StudyFrontiers in Aging Neuroscience, 2014
- Huntington disease: natural history, biomarkers and prospects for therapeuticsNature Reviews Neurology, 2014
- Dying at home – is it better: A narrative appraisal of the state of the sciencePalliative Medicine, 2013
- Indexing disease progression at study entry with individuals at‐risk for Huntington diseaseNeuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG), 2011
- Factors contributing to institutionalization in patients with Huntington's diseaseMovement Disorders, 2011
- Factors influencing death at home in terminally ill patients with cancer: systematic reviewBMJ, 2006
- A National Study of the Location of Death for Older Persons with DementiaJournal of the American Geriatrics Society, 2005
- Predictors of nursing home placement in Huntington diseaseNeurology, 2003
- Unified Huntington's disease rating scale: Reliability and consistencyMovement Disorders, 1996